Edition:
India

Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

73.69EUR
31 May 2016
Change (% chg)

€-0.22 (-0.30%)
Prev Close
€73.91
Open
€73.91
Day's High
€74.07
Day's Low
€73.32
Volume
2,332,720
Avg. Vol
3,066,081
52-wk High
€101.10
52-wk Low
€66.44

SASY.PA

Chart for SASY.PA

About

Sanofi SA is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging... (more)

Overall

Beta: 0.77
Market Cap(Mil.): €95,110.24
Shares Outstanding(Mil.): 1,286.84
Dividend: 2.93
Yield (%): 3.96

Financials

  SASY.PA Industry Sector
P/E (TTM): 21.88 35.48 36.41
EPS (TTM): 3.38 -- --
ROI: -- 13.75 13.11
ROE: -- 14.89 14.38

BRIEF-FDA recommends approval of Sanofi treatment for Type 2 Diabetes

* FDA advisory committee recommends approval of Sanofi treatment for adults with Type 2 Diabetes

26 May 2016

U.S. panel backs approval of Sanofi combination diabetes drug

One day after recommending approval of a new diabetes drug made by Novo Nordisk A/S, a U.S. advisory panel on Wednesday recommended approval of a similar product made by Sanofi SA.

26 May 2016

UPDATE 2-U.S. panel backs approval of Sanofi combination diabetes drug

May 25 One day after recommending approval of a new diabetes drug made by Novo Nordisk A/S, a U.S. advisory panel on Wednesday recommended approval of a similar product made by Sanofi SA.

26 May 2016

Exclusive: Sanofi to unveil challenge to Medivation's board - sources

France's Sanofi SA is preparing to name candidates it will put forward to replace the entire board of U.S. cancer drug company Medivation Inc as early as Wednesday, according to people familiar with the matter.

26 May 2016

Sanofi moves to oust Medivation board in $9.3 billion takeover fight

French drugmaker Sanofi named eight candidates to replace the entire board of Medivation Inc on Wednesday, stepping up pressure on the U.S. cancer drug company which has rejected its $9.3 billion takeover approach.

26 May 2016

UPDATE 3-Sanofi moves to oust Medivation board in $9.3 bln takeover fight

* Cancer drug company says $52.50 a share inadequate (Adds details on Medivation bylaws)

26 May 2016

BRIEF-Medivation says urges stockholders to reject Sanofi's attempt to replace co's board of directors

* Medivation urges stockholders to reject sanofi's attempt to replace medivation board of directors

25 May 2016

BRIEF-Sanofi sends letter to Medivation board of directors

* Sanofi files consent solicitation to remove and replace Medivation's board

25 May 2016

Sanofi names eight candidates to replace Medivation board

May 25 French drugmaker Sanofi on Wednesday named eight candidates to replace the entire board of Medivation, stepping up pressure on the U.S. cancer drug company, which has rejected its $9.3 billion takeover approach.

25 May 2016

BRIEF-Sanofi seeking shareholder support for removal of Medivation board

* Sanofi says seeking shareholder support for removal of board as of time removal proposal becomes effective and election of nominees

25 May 2016

Earnings vs. Estimates